• Investors
  • News
  • Careers
  • Contact
  • Global Need
    • Vaccines
    • History & Impact
  • Our Solution
    • Oral Vaccines
    • Technology
    • Vaccine Advantages
    • Platform Advantages
  • Pipeline
    • Research & Development
    • Norovirus
    • Influenza
    • RSV
    • HPV
  • About Us
    • Our Mission
    • Our Team
    • Careers
    • Contact
    • Compliance
  • Investors
  • News
  • Careers
  • Contact

Single

Karen Wilson

Karen J. Wilson has served as a member of our board of directors since August 2020. Ms. Wilson has more than 30 years of industry and leadership experience in life sciences companies across finance, strategy, and risk management. She currently serves as independent director and audit committee chair for Angion Biomedica, Connect Biopharma, and LAVA Therapeutics. Ms. Wilson served as senior vice president of finance at Jazz Pharmaceuticals plc until September 2020 after serving as vice president of finance and principal accounting officer. Prior to Jazz, Ms. Wilson was the vice president of finance and principal accounting officer for PDL BioPharma, Inc. She also held senior roles in finance and operations with ViroLogic, Inc. and Novare Surgical Systems, Inc. She is a Certified Public Accountant and holds a bachelor’s degree in business from the University of California, Berkeley.

Post navigation

Previous PostPrevious
Next PostNext
Media Contacts

Katie Hogan, WCG
415.658.9745
khogan@wcgworld.com

Samir Singh, Vaxart
908.720.622,4
ssignh@vaxart.com

Get Updates

Subscribe to receive news alerts now.

© 2021 Vaxart, Inc., All rights reserved. Terms of UsePrivacy Policy